PTCD2
Pentatricopeptide repeat-containing protein 2, mitochondrial
Also known as: FLJ12598, PTCD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WV60
- Gene
- PTCD2
- Ensembl
- ENSG00000049883
- Chromosome
- 5
- Canonical length
- 388 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in mitochondrion organization and regulation of mRNA processing. Predicted to act upstream of or within several processes, including liver development; muscle cell development; and ventricular cardiac muscle tissue morphogenesis. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
388 residues, UniProt reviewed canonical sequence.
>Q8WV60|PTCD2
1 MVRDSMAAAF RPSNRVLLQA LQILVYPGVG GSGSVSCRCP LGAKRYLLTD NVVKLKEFQQ
61 KKVAVACNLS GTKETYFRNL KKKLTQNKLI LKGELITLLH LCESRDHVEL AKNVIYRYHA
121 ENKNFTLGEY KFGPLFVRLC YELDLEESAV ELMKDQHLRG FFSDSTSFNI LMDMLFIKGK
181 YKSALQVLIE MKNQDVKFTK DTYVLAFAIC YKLNSPESFK ICTTLREEAL LKGEILSRRA
241 SCFAVALALN QNEMAKAVSI FSQIMNPESI ACINLNIIIH IQSNMLENLI KTLKNAAEGN
301 LSKFVKRHVF SEEVLAKVRE KVKDVPALVA KFDEIYGTLH ITGQVTTDSL DAVLCHTPRD
361 RKSHTLLLNK RMVSRRTFQP LSQSLLAELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTCD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- tongue: 13 nTPM
- choroid plexus: 11 nTPM
- skeletal muscle: 8.2 nTPM
- heart muscle: 6.9 nTPM
- parathyroid gland: 4.5 nTPM
- adrenal gland: 4.4 nTPM
Single-cell type
- choroid plexus epithelial cells: 63 nCPM
- cone photoreceptor cells: 33 nCPM
- rod photoreceptor cells: 27 nCPM
- cytotrophoblasts: 25 nCPM
- astrocytes: 24 nCPM
- ependymal cells: 24 nCPM
Immune cell
- NK-cell: 3.2 nTPM
- T-reg: 2.1 nTPM
- myeloid DC: 1.9 nTPM
- naive CD8 T-cell: 1.9 nTPM
- naive B-cell: 1.6 nTPM
- naive CD4 T-cell: 1.5 nTPM
Brain region
- choroid plexus: 10 nTPM
- white matter: 6.7 nTPM
- pons: 6.5 nTPM
- midbrain: 5.8 nTPM
- thalamus: 5.7 nTPM
- cerebellum: 5.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- kidney development
- liver development
- mitochondrion organization
- mRNA processing
- muscle cell development
- regulation of gene expression
- regulation of mRNA processing
- ventricular cardiac muscle tissue morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pentatricopeptide repeat
- Tetratricopeptide-like helical domain superfamily
- mS27/PTCD2
- Mitochondrial 28S ribosomal protein S27
- Pentatricopeptide repeat-containing protein 2, mitochondrial
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTCD2 as an antibody target. Whether an autoantibody or antibody against PTCD2 could matter depends on whether native PTCD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTCD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTCD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...